April 2020

Episode #289: The War on Cancer — Interview with Dr. Azra Raza

A Profound and Moving Conversation About Cancer, Dr. Azra Raza’s Research, and Her Life Experiences

dr azra raza.jpg

A Bit More About Dr. Azra Raza

Dr. Azra Raza is the Chan Soon-Shiong Professor of Medicine and Director of the MDS Center at Columbia University in New York. She is considered an international authority on pre-leukemia (MDS) and acute leukemia and is one of those rare physician-scientists who divide their time equally between caring for patients and supervising a state-of-the-art basic research lab which is well-funded by multiple large grants.

Dr. Raza started collecting blood and marrow samples on her patients in 1984 and now her Tissue Bank, the largest and oldest in the country with >60,000 samples, is considered a unique national treasure. Dr. Raza has published her original clinical and basic research comprising over 300 peer-reviewed manuscripts in high profile journals like Nature, New England Journal of Medicine, Cell, Molecular Cell, Cancer Research, Blood, Leukemia. She is the author of The First Cell: And the Human Costs of Pursuing Cancer to the Last published October 2019.

Here are Ron’s questions from the interview:

  • Welcome to TSOE, Azra. It is such an honor to get to speak with you. Before we get into your book, during this COVID crisis, how are you holding up, personally?

  • Do you still have to see some patients for cancer treatments?

  • The First Cell: And the Human Costs of Pursuing Cancer to the Last, Amazons Best Science book of 2019.

  • Azra, we were introduced to you and your book from Russ Robert’s podcast, EconTalk, Ed’s and my favorite podcast. We jokingly refer to TSOE as the “poor man’s Econtalk.” I read your book after hearing the interview, and Russ Roberts said it best: Your book is hard to read, and harder to put down.” It is beautifully written. I had to stop to cry many times, I lost count. It’s so human, so profound, thank you for writing it and educating us lay people on the effects of cancer. Let’s start with what type of cancer you specialize in.

  • You actually started in pediatric oncology and couldn’t handle it, is that right?

  • You write, Today, one in two men and one in three women will get cancer. Nearly 18 million worldwide. You wrote:

    • My surroundings may not have changed much, but my perceptions have.

    • Like the difference between illness and disease; between what it means to cure and to heal; between what it means to feel no pain and to feel well.

    • I have felt like a fraud, a posturing intellectual phony. In the march to death, I have begun to catalog the tragedies of survival.

  • That is profoundly self-introspective. What brought on these feelings?

  • You write that “treatments for cancer haven’t changed in 50 years. Cancer treatment was just as primitive a century ago. With minor variations, a protocol of surgery, chemotherapy, and radiation—the slash-poison-burn approach to treating cancer—remains unchanged. It is an embarrassment. Equally embarrassing is the arrogant denial of that embarrassment.” Azra, why is that?

  • Azra, before we get into the more hopeful things, I just want to ask you one more thing. You say no one is winning the war on cancer. It is mostly hype. I would think most folks probably think since president Nixon declared a war on cancer progress we have been making progress. What’s the disconnect there?

  • Let’s pivot to your strategy and the name of your book. You think the strategy is to stop chasing after the last cancer cell and focus on eliminating the first. You believe experiments with animals, mice in particular, don’t teach us much on how treatments will work in humans. Is it really possible, Azra, with your strategy to reduce cancer deaths by 75 percent?

  • When you say the first cell, you quoted one of your colleagues who basically said that early detection screening for cancer has not fulfilled our expectations, PSA tests, things like that. You’re actually talking about things that are being worked on like a machine that automatically images your body while you are in the shower, or wearing a smart bra that has two hundred tiny biosensors, and other ways of measuring things from your urine, blood, and saliva. You’re optimistic that some of things they are working will come to fruition?

  • Azra, is a cancer vaccine possible?

  • Azra, this was painful for me to read: “I wish I felt like an exceptional oncologist. Most days, I feel like a complete failure.” I have to tell you, even though I know you work against great odds, my Mom is a three-time cancer survivor, she had Uterus, Breast, and liver cancer. Her oncologists are heroes to me, because she’s still living at 87. You tell a story at the end of the book about walking in the mall with your older sister and your brother, Tasnim, a cardiac surgeon at Buffalo General Hospital, and people were running up to him and hugging him. Your mother said: “You have been in Buffalo for almost ten years. I have never met any of your patients. Why are heart patients doing so much better than cancer patients?” Wow, that’s profound.

  • Azra, we’re at the end of our time together, and I just wanted to point out the other thing I learned from your book that I just loved, I didn’t know that “The response to a greeting from a younger person in Arabic is often, ‘May you live to bury me.’ That is beautiful. Ed will take you home, thank you so much for appearing on TSOE. 

…and here are Ed’s questions:

  • I learned so much about cancer from your book. The thing that struck me was the complexity of cancer. As a layperson, I think we look at disease as monolithic. You write in the book, “If you biopsy a patient with breast cancer twice in the same day, once in the breast and once in the lymph node, you can get cancer cells with different sequences.” So cancer is not the same in the same person even hours apart, or even in different parts of their body. I never realized the level of complexity, can you expound on that?

  • You mention the four different causes. Do we think those different causes cause the different forms of cancer, or could all four of those cause similar cancers?

  • The complexity of what is happening with COVID is an example of a macrocosm of the cancer cell. It is so complex, and you are talking about small little cells in the body, and now we are trying to figure this out for all of society. I just thought it was an interesting parallel.

  • Would you address the so-called CAR-T therapies that are being developed?

  • Another treatment going after the last cell rather than the first cell, hence the name of your book. Hopefully for the second half of our conversation we can begin to transition over to the positive side of things and what you’re doing to get people to think about this differently.

  • I wanted to take us in a different direction. I was intrigued about smart bras, etc., to detect cancer. Are there privacy concerns with this scanning, like with 23andMe worries about some insurance company is going to find about the results. Are there are any privacy concerns we have to worry ourselves with regards to this type of screening?

  • Talk a little about the research lab you run. You created this lab two decades ago, is that correct?

  • I wish I had $200 million to give you. Hopefully, we’ll help get your message out. Is there anyone else who has done anything similar?

  • One of the things that is also great about your book is it is peppered with great references to literature, I know it’s something you are very passionate about. I’m a word guy as well, and I found the whole thing about “pharmakon,” the Greek word meaning remedy, poison, and sacrifice. Do I have that right?

  • One of the things I wanted to share with you, is the importance of art and literature in the treatment of us as human beings. I also saw this in one of your videos as well, the whole notion of sacrifice came out, I was reminded of the William Butler Yeats poem, “Easter 1916,” I’m going to share part of it with you that I’ve committed to memory:

Too long a sacrifice
Can make a stone of the heart.   
O when may it suffice?
That is Heaven's part, our part   
To murmur name upon name,   
As a mother names her child   
When sleep at last has come   
On limbs that had run wild.   
What is it but nightfall?
No, no, not night but death;   
Was it needless death after all?
For England may keep faith   
For all that is done and said.   
We know their dream; enough
To know they dreamed and are dead;   
And what if excess of love   
Bewildered them till they died?   
I write it out in a verse—
MacDonagh and MacBride   
And Connolly and Pearse
Now and in time to be,
Wherever green is worn,
Are changed, changed utterly:   
A terrible beauty is born.

Dr. Raza ended by citing Emily Dickinson’s poem, “I measure every Grief I meet”:

I measure every Grief I meet
With analytic eyes – 
I wonder if It weighs like Mine – 
Or has a different size. 

I wonder if They bore it long – 
Or did it just begin – 
I cannot find the Date of Mine – 
It been so long a pain – 

I wonder if it hurts to live – 
And if They have to try – 
And whether – could They choose between – 
They would not rather – die – 


Bonus Content is Available As Well

Did you know that each week after our live show, Ron and Ed take to the microphone for a bonus show? Typically, this bonus show is an extension of the live show topic (sometimes even with the same guest) and a few other pieces of news, current events, or things that have caught our attention.

Click the “FANATIC” image to learn more about pricing and member benefits. 

Episode #288: Interview with Accounting Thought Leader Doug Sleeter

Blockchain, Bitcoin, and The Future of Accounting — This was a GREAT episode featuring Doug Sleeter

doug sleeter copy.png

A Bit More About Doug

DougSleeter (@dougsleeter) is the founder and former CEO of The Sleeter Group, an international network of accounting software consultants, and the former producer of SleeterCon, an annual conference for accounting professionals. As a CPA firm veteran and former Apple Computer Evangelist, he melded his two great passions (accounting and technology) to guide developers in the innovation of new products and to educate and lead accounting professionals who serve small businesses. He is currently focusing on digital currencies and blockchaintechnology. He was inducted into The CPA Practice Advisor Hall of Fame in the accounting profession, and named to Accounting Today's "Top 100 Most Influential People in Accounting," 2008-2015. Doug attended the University of California Santa Cruz and Santa Clara University, holds a Bachelor of Arts degree in Computer Information Systems, and lives in Pleasanton, CA.

Here are Ed’s questions from the interview:

  • Doug, welcome back to the show. You were on twice before (Episode #96 and #99), back in June 2016. Feels like that was an eon ago, doesn’t it?

  • Just to remind folks who don’t know, who’s this Doug Sleeter guy?

  • Let’s do a quick update on where you’re seeing blockchain. What’s your latest thinking around where blockchain is today?

  • There was use case with tuna, but we’re not talking about Internet of Things, it’s really more the process and production stage of things, correct

  • It’s similar to our fingerprint and facial recognition on our mobile devices today, that information is stored locally on the device, and not something the government is using to track us. We need airport security, but I think it should be run by the airlines and not the government.

  • Blockchain might be a partial answer to keep our data private and secure, which is part of the promise of the blockchain.

  • I tend to trust the private sector slightly more than the public sector just because as a customer I can change, whereas as a citizen I’m pretty stuck, unless I move to a different country.

  • I don’t think any of the three of us believes that COVID is no big deal, or less than the flu. But the unknowns with the data are a problem. A recent study by Stanford, on the “denominator” we could have missed it by a factor of 50-85 times. I just want to get your take on this. It’s furthering your point, but what are your thoughts on this? This is something we have to be on the lookout for, not just for COVID, but from a business perspective.

  • I want to pivot over to a book I recommended to you, which I mentioned on our show, Best Books of 2019 (Episode #275), and on my list was a book called The Case Against Reality by Donald Hoffman. I noticed just three days ago you posted a review on your GoodReads page.

  • In your review, you write at the end about how its helped you further your thinking about creativity and what does consciousness mean for robots, and the last sentence is “But I'm pretty sure we'll create robots that we won't be able to distinguish from conscious beings.” My question is what led you to that conclusion, because I’ve come to the exact opposite conclusion, which is pretty cool?

  • I don’t think we can get there, because I can’t prove your consciousness, so how do I go about proving the consciousness of this robot? I guess it could fool us, but we still wouldn’t know, because we can’t prove conscious in another being anyway.

  • I just love his notion that the fundamental element of the world is not space time, but rather consciousness. That’s the thing that just blew my mind about the book. He does a great job using evolution to prove his theory.

  • What are your thoughts on what you are seeing in the accounting market now? 

     

    …and here are Ron’s questions:

  • On blockchain, Bill Gates has that famous line: “We overestimate technology’s short-term impact, and under-estimate its long-term impact. Have we hit the long-term impact with blockchain [and Bitcoin], or are we still in the experimental, early stages?

  • George Gilder talks about blockchain being the 7th layer of the internet, that trust and transactions layer, it’s going to be built into the architecture. To get us over that hump, will this technology need to be taken on by an Amazon, Google, Facebook, combination thereof, to democratize it and make it more understandable, or is it something that will be just layered on the Internet and we’ll never talk about it?

  • Did you have an opinion on Facebook’s Libra?

  • Since we last spoke in 2016, have you changed your mind or evolved your thinking about Bitcoin or blockchain?

  • They have to work on that volatility of value, a currency has to be stable, it’s a measuring stick. You can’t float the ruler, a foot always has to be 12 inches.

  • I’m going to pivot to COVID-19. You’ve been talking since I’ve known you about Big Bad Data, and we are getting a real live example of that on just the numbers these various websites are tracking, number cases, number of deaths, mortality. What’s your take on all this, does it just confirm your priors about how dangerous data can be?

  • I couldn’t agree with you more that we need to blow the whole accounting infrastructure up and start over. Triple entry accounting made possible by blockchain is the route. But the other thing you said that I loved: When people roll their eyes you know you’re on to something. That is so true. When people are scared of a new idea, that’s how you know it’s a great idea. The dog barks at what he doesn’t understand.

  • Doug, one of our prior guests was economist Tyler Cowen (Episode #240) he does something he calls Overrated or Underrated, and Why on his podcast, Conversations with Tyler:

    • TED talks [Both]

    • Living in California [Overrated]

    • The Masters [Underrated]

    • Pebble Beach golf course [Underrated]

    • Retirement [Underrated]

    • Donald Trump [Underrated]

    • Apple, Inc. [Underrated]

    • Income inequality [Overrated]


Bonus Content is Available As Well

Did you know that each week after our live show, Ron and Ed take to the microphone for a bonus show? Typically, this bonus show is an extension of the live show topic (sometimes even with the same guest) and a few other pieces of news, current events, or things that have caught our attention.

Click the “FANATIC” image to learn more about pricing and member benefits. 

Here are some of the topics and links Ron and Ed discussed during the bonus episode this past week:

Episode #287: Second interview with Jody Thompson

The Results-Only Work Environment was co-created by our guest, Jody Thompson. Employees should be paid for results (output) rather than the number of hours worked.

jody thompson.png

A Bit More About Jody

Jody Thompson is a world-recognized future workplace expert and change-maker who has been featured on the covers of BusinessWeek, Workforce Management Magazine, HR Magazine, and HR Executive Magazine, as well as in the New York Times, TIME Magazine, USA Today, and on Good Morning America, CNBC, MSNBC and CNN. Jody is the co-creator of the proven management innovation system, the Results-Only Work Environment™ (ROWE™).

Here are Ron’s questions from the interview:

  • Welcome back Jody! You were on December 12, 2014 (Episode #24). How are you, personally, holding up during these interesting times?

  • You traveled quite a bit didn’t you?

  • Last time, we discussed your book with Cali Ressler, Why Work Sucks and How to Fix It. For new listeners, define the Results-Only Work Environment™ (ROWE™).

  • I don’t want to gloss over this. This is an important point. In your biography, it says that you are the co-creator of the proven management innovation system. Innovations in management have been far and few between. We’re still running on a lot of ideas developed in the 1880s to 1950. This is the great point Gary Hamel makes in his book, The Future of Management. Your innovation is an enormous accomplishment, so kudos for that; you’ve really contributed something that has legs for a long time.

  • When I first saw you and Cali Ressler speak, it was at a conference back in 2008, and in the restroom afterwards—where you get the real feedback from a presentation—people were saying things like, “Well, it’s interesting in theory, but it would never work in my organization.” How has ROWE™ been diffusing amongst the corporate world since the last time we spoke five-and-a-half years ago?

  • Here's a comment and question we got from one of our listeners, Wendy:

    • First thanks to Jody and Ed and Ron who opened my mind to so many possibilities I’m so grateful.

    • The question, now that organizations are forced to realize their thinking was flawed regarding the need to be in the office, how do you see the post Covid-19 landscape changing, do you anticipate that those organizations who insisted on face time will find justification to go back to their old ways?

  • You’re not just buying a block of time from an employee, but a group of work they can get done.

  • The whole presenteeism idea, I need to see you in a cubicle. It’s the illusion of control, isn’t it, for some of these managers?

  • In a knowledge economy, it’s much easier to slack off than if you worked in an auto factory. At least there, the person next to you on the line would know if you weren’t doing your job.

  • One of my favorite lines of yours: you manage the work, not the people.

  • Jody, I’ve been dying to ask you this question. I read the book by Eric Schmidt, How Google Works, and I’ve also read this about Apple, Pixar, and some other high-tech companies. They actually want people to be present because they think those serendipitous encounters lead to more innovation. I know we talk about working remotely, but ROWE™ is not just about working remotely. Wouldn’t ROWE™ work even in Google, or Apple, where your present but your focused on the outcomes?

  • I’m going to play the devil’s advocate, which is really hard since you’re preaching to the choir here. I can hear somebody say, “Yeah, but Jody, Apple and Google are two of the most successful companies on the planet (Pixar, too). Don’t you think they know what they are doing?

  • Gallup does that engagement poll every year, or every other, and they ask if employees feel connected to their organization’s strategies. So what you say has a lot of truth in it.

  • Another favorite term of mine that you developed—and the framework around it—can you describe is “Sludge.”

  • The other issue I’ve been curious about is government regulations. We have AB5 here in California that’s clamping down on Uber, Lyft, and even free-lance journalists. What about the regulations? Do you see the regulations loosening up to make ROWE™ more viable, such as overtime and other laws?

  • The whole work-life balance and flextime, it created a lot of confusion.

  • What has changed in your thinking since we last spoke?

  • Do you still hear the same objections? Have you heard any new objections? You had a whole chapter in the book of “Yeah, Buts.” Any new ones?

  • And you’ve shot all these objections down, and they keep coming back like termites!       

…and here are Ed’s questions from the interview from Jody

  • V.I. Lenin, the communist leader, said “That nothing happens for decades and then decades happen in weeks.” I think that’s what has happened to many of us. Like many organizations, Sage had a tele-work policy, and there were some positions which there was no way you could do this job from home, too much confidential information, etc. Very real concerns, I don’t want to dismiss them. When this COVID-19 thing came down, we really made a fantastic transition in two weeks to all of our colleagues working from home. Isn’t it funny. How long are you involved in making these transitions, but when it’s got to get done, we can get it done in two weeks?

  • You define the position by the results you need to achieve, it doesn’t matter how or where you get it done, we really don’t care. We ask people what they would do if we took away timesheets, and they say “We’d actually have to be clear about what we wanted.” We’d have to have clarity around what we expected from people.

  • Nowhere has this been made more apparent to me than with my fourteen-year-old son, who has moved into “remote learning” (why can’t it be just learning?). He’s in the 8th grade and gets his assignments on Monday, and he’s finished by noon on Wednesday. “I told you this was a colossal waste of time, dad.” That’s an experience companies are going to see as well. What if people actually performed better during this time period, what are we going to do then?

  • We’re going to do a future show on Price’s Law: In any system, the square root of the number of people do half the work. For example, in professional hockey, if you take the square root of the number of players in the NHL, that number of people score 50% or more of the goals. This pattern is repeated over and over, with composers, business organizations. It’s a flip on the Pareto principal, the 80/20 rule. Wouldn’t ROWE™ be a way to potentially smooth out Price’s Law a bit, since the focus in getting the work done, and working together to achieve results.

  • Here was the key learning for me: it begins in school. There’s absolutely presenteeism there.

  • With all this COVID-19 stuff that has happened, is there a tiny part of you that’s saying, “Told you so”?

  • Wendy has a follow-up question: could you address the notion of workplace specific roles. She thinks a lot of people get confused that ROWE™ means that nobody comes to work anymore.

  • What about the notion of workplace roles. There are certain roles that require some kind of presence at a particular place and time. For example, if you’re working in retail, you have to be at the store to get your work done?

  • One of the most important take-aways for me is not only do people need freedom—autonomy as you say—but they also participate in accountability as well. Peter Block—another guest on the show, see Episode #183—accountability and freedom are really the same thing. We choose to be accountable, it can’t be imposed on us. When people choose to be accountable, it really becomes clear that you have to produce the results, and if you don’t, you can’t participate in the payroll program.

  • All this leads to trust, right? Another maverick is Ricardo Semler out of Brazil, who wrote a book called Maverick. He has a great story about how when he gives out credit cards to his employees he says they don’t audit them, we just trust you. If you need something to do your job better, just buy it. People think he’s nuts, but employees can do millions of dollars of damage in a customer relationship, but I’m not going to trust them with a $500 monitor if they need it?


Bonus Content is Available As Well

Did you know that each week after our live show, Ron and Ed take to the microphone for a bonus show? Typically, this bonus show is an extension of the live show topic (sometimes even with the same guest) and a few other pieces of news, current events, or things that have caught our attention.

Click the “FANATIC” image to learn more about pricing and member benefits. 

Here are some of the topics and links Ron and Ed discussed during the bonus episode this past week:

Episode #286: Talking Coronavirus with Dr. Paul Thomas

Now with show notes! Thank you to our awesome listeners for being patient with us while we produced the audio early and then went back to add the show notes.

A Quick Bit About Dr. Paul Thomas

Dr. Paul Thomas is a board-certified family medicine physician practicing in Corktown Detroit. His practice is Plum Health DPC, a Direct Primary Care service that is the first of its kind in Detroit and Wayne County. His mission is to deliver affordable, accessible health care services in Detroit and beyond. He has been featured on WDIV-TV Channel 4, WXYZ Channel 7, Crain's Detroit Business and CBS Radio. He has been a speaker at TEDxDetroit. He is a graduate of Wayne State University School of Medicine and now a Clinical Assistant Professor. Finally, he is an author of the book Direct Primary Care: The Cure for Our Broken Healthcare System.

Here are Ed’s questions from the interview:

  • How are you?

  • What about the people in your local community, how’s it going there?

  • About 40% of hospital beds in Michigan are filled with COVID patients, does that sound right?

  • Is there a difference between intubation and being on a ventilator, or are they the same thing?

  • And that’s different from being on oxygen?

  • There are potentially long-term risks with being intubated, even after you come off it, such as challenges with your lung capacity coming back?

  • What has been the effect, if any, on your business model? Has there been any significant challenges with Direct Primary Care (DPC) model?

  • Are they waiving any regulations to be able to provide telemedicine, for example?

  • Do you think COVID-19 might lead to a significant increase in DPC?

  • Will doctors get acclimated to provide telemedicine?

  • The numbers we’re all seeing at John Hopkins or Worldometer, the numbers are pretty scary, but they are also are staggeringly incomplete. I don’t think we can really believe the number of cases in China being limited to 81,000, for instance.

  • You talked a little bit about the tests with Ron, what are your thoughts about the at-home tests? Will we all be able to test ourselves at home and get some better numbers about what’s happening?

  • The FDA and CDC sort of messed up the process with the test when all this began. What are your thoughts on that?

  • This is less political than governmental. The nature of bureaucracy that may have been the downfall, regardless of the administration.

  • On your website blog, you did a great job debunking the Vitamin C myth that’s out there. What about hydroxychloroquine as a possible treatment?

  • What about the potential vaccine for this? If one was quickly developed would we be able to get it out quick enough, or would that run into bureaucratic hurdles?

  • Does that 15-18 months include the testing and verification, or just the development of a vaccine?

  • What about links you’ve seen to diabetes or pre-diabetic condition, or does it mostly just affect those who are older?

  • Age and diabetes are correlated aren’t they?

…and here are Ron’s questions:

  • In times like this, do you think this business model has deepened your relationship with patients?

  • Do you think the subscription model helps you weather a storm like this rather than a more transactional business model?

  • Can you explain the protocol for a COVID-19 test? Don’t they test for the flu first, and only as a last resort test you for COVID-19?

  • We don’t have a clear idea of the “denominator,” we don’t how many people are walking around with asymptomatic symptoms, right?

  • Settle a big dispute: Should we be wearing masks when we go out? [Yes!]

  • Does it have to be an N95 mask? [No]

  • You probably remember that in 2009-10 we had the Swine Flu, and between April 12, 2009 and to April 10, 2010, 12,469 people died in the USA alone, with 87% being under age 65. What makes COVID-19 deadlier than the swine flu?

  • Can this can back in different strains? Can you get again once you’ve had it and recovered?

  • Have you seen any granular demographic, age, comorbidities information on the reported deaths and/or cases?

  • With older patients, there’s a difference between dying from and dying with corona virus. How do they make that distinction when they gather the death statistics?

  • The University of Pittsburgh has developed a vaccine, they say they’ve seen development antibodies in mice. And I just finished a book by the oncologist Dr. Azra Raza, who wrote The First Cell. She says, at least for cancer, having anything to do with mice doesn’t really work when translating to humans. But is that not true with vaccines? The fact it works with mice, is that promising for humans?

  • We say it takes 12-18 months to develop a vaccine. Is there a way for the FDA to expedite this process. What is the risk of a vaccine developed quickly?

  • On your website blog video from March 26, 2020 you answer the question, “How can I become immune?” You listed two ways:

    • Get Infected then Recover (your body produces IGM/IGG) and you now have the antibody

    • Vaccination

  • You said to create herd immunity you need 50-60% of people, can that immunity happen plasma transfusions from people who had the virus and recovered?

  • What about this virus running it course and achieving of herd immunity? How long does that process take without a vaccine?

  • Unless it comes back in a different strain?

  • I’m looking at Worldometer, and Michigan has now surpassed California in cases. We were taking flights from China during December and January, at the rate of at least 7,000 per day. There’s only 246 deaths in CA—each a tragedy—can you account for that? Why wasn’t CA hit has hard as New York, New Jersey, or even Michigan?

  • Could it be herd immunity, why CA wasn’t hit as hard?

  • Where do you see this ending? How and when?


Bonus Content is Available As Well

Did you know that each week after our live show, Ron and Ed take to the microphone for a bonus show? Typically, this bonus show is an extension of the live show topic (sometimes even with the same guest) and a few other pieces of news, current events, or things that have caught our attention.

Click the “FANATIC” image to learn more about pricing and member benefits. 

Here are some of the topics and links Ron and Ed discussed during the bonus episode this past week:

  • After spending an hour with Dr. Paul Thomas, Ron and Ed discuss the potential impact of "hitting the pause button" on a $30 trillion economy. Hint: We have no freaking clue and neither does anyone else.